Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematologic disorders affecting the lungs.

J R Edwards1, K K Matthay

  • 1Department of Pediatrics, University of California, San Francisco, School of Medicine.

Clinics in Chest Medicine
|December 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma.

Nature communications·2024
Same author

Image-Guided Transvaginal and Transabdominal Drain Placement for Surgical Navigation in a Patient with Tubo-Ovarian Abscess and Obstructed Hemivagina and Ipsilateral Renal Anomaly Syndrome.

Journal of pediatric and adolescent gynecology·2021
Same author

A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo.

Molecular cancer·2017
Same author

Epigenetic activation of the prostaglandin receptor EP4 promotes resistance to endocrine therapy for breast cancer.

Oncogene·2016
Same author

Persistence of Influenza A (H1N1) Virus on Stainless Steel Surfaces.

Applied and environmental microbiology·2016
Same author

MS2 Coliphage as a Surrogate for 2009 Pandemic Influenza A (H1N1) Virus (pH1N1) in Surface Survival Studies on N95 Filtering Facepiece Respirators.

Journal of the International Society for Respiratory Protection·2015
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Hematologic disorders can affect the lungs through various mechanisms, leading to conditions like pulmonary hemorrhage or fibrosis. Early diagnosis and management of these blood disorders are crucial for preventing severe lung complications and improving patient outcomes.

Area of Science:

  • Hematology
  • Pulmonology
  • Internal Medicine

Background:

  • Hematologic disorders can manifest in the lungs through hemostasis abnormalities, cellular defects, or direct malignancy involvement.
  • Understanding these mechanisms is key to recognizing pulmonary complications such as hemorrhage, thromboembolism, fibrosis, and obstruction.

Purpose of the Study:

  • To highlight the diverse mechanisms by which hematologic disorders impact pulmonary physiology.
  • To emphasize the importance of early diagnosis and management of hematologic conditions to prevent pulmonary sequelae.

Main Methods:

  • Review of mechanisms linking hematologic disorders to pulmonary pathology.
  • Analysis of diagnostic considerations for blood-related lung diseases.
  • Discussion of therapeutic strategies for acute and chronic pulmonary manifestations.

Related Experiment Videos

Main Results:

  • Hematologic abnormalities can lead to significant pulmonary issues, including hemorrhage, thromboembolism, fibrosis, and obstruction.
  • Prompt diagnosis and management of the underlying hematologic disorder are essential for mitigating lung damage.

Conclusions:

  • Early intervention in hematologic disorders can prevent long-term pulmonary complications.
  • Integrated management of acute pulmonary symptoms and chronic hematologic disease improves patient prognosis and quality of life.